scholarly article | Q13442814 |
P50 | author | Anders Woetmann | Q38318495 |
Michal Marzec | Q39065406 | ||
Xiaobin Liu | Q87165894 | ||
Mariusz A Wasik | Q87224772 | ||
P2093 | author name string | Michael Milone | |
Qian Zhang | |||
John K Choi | |||
Monika Kasprzycka | |||
Agnieszka Witkiewicz | |||
Alain H Rook | |||
Niels Odum | |||
Samik Basu | |||
Eric Vonderheid | |||
Magdalena Potoczek | |||
Joanne Mauger | |||
Hong Yi Wang | |||
J Todd Abrams | |||
J Steven Hou | |||
P2860 | cites work | Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells | Q22009002 |
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function | Q24290522 | ||
FOXP3 controls regulatory T cell function through cooperation with NFAT | Q24298179 | ||
Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1 | Q24300625 | ||
Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation | Q28270256 | ||
IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21 | Q28270764 | ||
The STATs of cancer--new molecular targets come of age | Q29614601 | ||
IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells | Q34318928 | ||
Signal transducer and activator of transcription 5 (STAT5). | Q34341424 | ||
WHO-EORTC classification for cutaneous lymphomas | Q34391006 | ||
Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development | Q34597933 | ||
Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3 | Q34773094 | ||
Nonredundant roles for Stat5a/b in directly regulating Foxp3 | Q35828667 | ||
Regulatory T cells and mechanisms of immune system control | Q35852343 | ||
Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype | Q36059631 | ||
Regulatory T cells and tumor immunity | Q36114473 | ||
Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines | Q36239779 | ||
Cd4+Cd25+ regulatory T cells and their therapeutic potential | Q36366885 | ||
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. | Q36402501 | ||
Future perspectives in the treatment of cutaneous T-cell lymphoma (CTCL). | Q36413663 | ||
IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes. | Q36445869 | ||
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design | Q36547207 | ||
Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma. | Q37052602 | ||
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome | Q37387679 | ||
FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival | Q40090775 | ||
Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells | Q40383822 | ||
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo | Q42139164 | ||
Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor | Q43948616 | ||
Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor | Q44639305 | ||
Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency | Q46893433 | ||
Deacetylase inhibition promotes the generation and function of regulatory T cells. | Q46961808 | ||
IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. | Q51998742 | ||
A role for regulatory T cells in cutaneous T-Cell lymphoma; induction of a CD4 + CD25 + Foxp3+ T-cell phenotype associated with HTLV-1 infection. | Q55239445 | ||
Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells | Q56903036 | ||
Differential regulation of T-cell growth by IL-2 and IL-15 | Q59748325 | ||
IL-21 Enhances Antitumor Responses without Stimulating Proliferation of Malignant T Cells of Patients with Sézary Syndrome | Q60711900 | ||
IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity | Q77995572 | ||
IL-2Rbeta links IL-2R signaling with Foxp3 expression | Q80455481 | ||
Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells | Q81326661 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | phenotype | Q104053 |
P304 | page(s) | 2506-2512 | |
P577 | publication date | 2008-08-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes | |
P478 | volume | 181 |
Q51603241 | Anti-gamma chain and anti-IL-2Rbeta mAbs in combination with donor splenocyte transfusion induce H-Y skin graft acceptance in murine model. |
Q45738584 | Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sézary syndrome |
Q37139517 | Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma |
Q64235755 | Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma |
Q38909786 | Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells |
Q38714687 | Cutaneous T cell lymphoma expresses immunosuppressive CD80 (B7-1) cell surface protein in a STAT5-dependent manner |
Q27024076 | Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and management |
Q36470196 | Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management |
Q48034709 | Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management. |
Q37967108 | Cutaneous lymphomas: molecular pathways leading to new drugs |
Q40531806 | Expression patterns of the immunosuppressive proteins PD-1/CD279 and PD-L1/CD274 at different stages of cutaneous T-cell lymphoma/mycosis fungoides |
Q84278927 | FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome |
Q59050199 | FoxP3-Positive T-Regulatory Cells in Lymph Nodes with Mycosis Fungoides and Sézary Syndrome |
Q36392832 | Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cells |
Q33728396 | IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF). |
Q39586865 | Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway |
Q37723390 | Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover |
Q38757938 | Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma |
Q55407685 | Mycosis fungoides progression could be regulated by microRNAs. |
Q38162229 | NFκB function and regulation in cutaneous T-cell lymphoma |
Q37081609 | Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1). |
Q35220408 | Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS |
Q37929548 | Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome. |
Q36675064 | Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma |
Q33987080 | Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation. |
Q94503541 | Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma |
Q94686468 | Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome |
Q26746551 | Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets |
Q54117760 | The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL). |
Q41573605 | The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines |
Q34672100 | The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells. |
Q37975058 | The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma |
Q37408217 | Transcriptional regulation of Foxp3 gene: multiple signal pathways on the road |
Search more.